Homozygosity Mapping Places the Acrodermatitis Enteropathica Gene on Chromosomal Region 8q24.3  by Wang, Kun et al.
Am. J. Hum. Genet. 68:1055–1060, 2001
1055
Report
Homozygosity Mapping Places the Acrodermatitis Enteropathica Gene
on Chromosomal Region 8q24.3
Kun Wang,1 Elizabeth W. Pugh,2 Shari Griffen,1 Kimberly F. Doheny,2 Wedad Z. Mostafa,3
Mustafa M. al-Aboosi,4 Hatem el-Shanti,5 and Jane Gitschier1
1Howard Hughes Medical Institute and Departments of Medicine and Pediatrics, University of California, San Francisco; 2Center for Inherited
Disease Research, Johns Hopkins University, Baltimore; 3Department of Dermatology, Faculty of Medicine, Cairo University, Cairo; and
Departments of 4Dermatology and 5Pediatrics and Medical Genetics, Jordan University of Science and Technology, Irbid, Jordan
Acrodermatitis enteropathica (AE) is a rare autosomal recessive pediatric disease characterized by dermatitis, di-
arrhea, alopecia, and growth failure. The disease results from insufficient uptake of zinc by the intestine and can
be fatal unless the diet is supplemented with zinc. To map the gene responsible for AE, a genomewide screen was
performed on 17 individuals, including 4 affected individuals, in a consanguineous Jordanian family. Three
markers—D8S373, D10S212, and D6S1021—had a pattern consistent with tight linkage to a recessive disease:
one allele in the affected sibs and multiple alleles in unaffected sibs and parents. Two-point parametric linkage
analysis using FASTLINK identified one region, D8S373, with a maximum LOD score 11.5 (1.94 at D8S373:
recombination fraction .001). Twelve additional markers flanking D8S373 were used to genotype the extended
family, to fine-map the AE gene. All five affected individuals—including one who was not genotyped in the ge-
nomewide screen—were found to be homozygous for a common haplotype, spanning ∼3.5 cM, defined by markers
D8S1713 and D8S2334 on chromosomal region 8q24.3. To support these mapping data, seven consanguineous
Egyptian families with eight patients with AE were genotyped using these markers, and six patients from five families
were found to be homozygous in this region. Multipoint analysis with all consanguineous families, by Mapmaker/
Homoz, resulted in a maximum LOD score of 3.89 between D8S1713 and D8S373. Sliding three-point analysis
resulted in a maximum LOD score of 5.16 between markers D8S1727 and D8S1744.
Acrodermatitis enteropathica (AE [MIM 201100]) is
an inborn error of metabolism resulting in zinc mal-
absorption and severe zinc deficiency. Symptoms in-
clude intermittent simultaneous occurrence of diarrhea
and dermatitis, alopecia, and failure to thrive (Dillaha
et al. 1953; Van Wouwe 1989). The disorder usually
manifests at the time of weaning—or earlier, in infants
who are not breast-fed—and can be fatal if untreated.
Symptoms other than dermatitis vary with age, and
spontaneous remission may occur at adolescence.
Barnes and Moynahan (1973) first observed that the
disorder was caused by the inability to absorb sufficient
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zinc, and they achieved a complete cure of all symptoms
by zinc supplementation alone. Decreased zinc absorp-
tion (Lombeck et al. 1975; Weismann et al. 1979; van
den Hamer et al. 1985) and impaired zinc uptake in
vitro, evidenced by biopsy of jejunal mucosa (Atherton
et al. 1979), were later demonstrated using 65Zn or
69mZn. Zinc supplementation is effective in the treat-
ment of the disease, presumably because the increase
in luminal zinc concentration is such that the diffu-
sional component of zinc transport is stimulated (Da-
vies 1980; Steel and Cousins 1985).
The variability of symptoms in patients of different
ages makes clinical diagnosis of AE difficult. Typically,
plasma- and serum-zinc concentration, as well as urinary
excretion of zinc, are half the normal levels (VanWouwe
1989). However, serum-zinc level is not completely di-
agnostic, since zinc levels in children are susceptible to
a range of conditions (Nishi et al. 1980; Naveh et al.
1982; Rodriguez et al. 1985; Van Wouwe et al. 1988).
In cases of doubtful diagnosis, zinc-absorption tests us-
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Figure 1 Jordanian pedigree with AE. A, Patient (corresponding to the filter card in the pedigree) showing perianal skin lesions. The
perioral region shows an exudative and crusted area on an erythematous base, with irregular outline. The scalp hair is sparse, diarrhea is
present, and the elbows and knees show scaly erythematous and thickened skin (psoriasiform). Periungal erythema and slightly swollen folds
are present, and the nape of the neck shows slight psoriasiform rash. B, Haplotypes of the Jordanian pedigree, for 13 microsatellite markers
at 8q24.3. Haplotypes were constructed by inspection, and those that are homozygous in affected individuals are boxed.
Table 1
Markers with a LOD Score 0.75, from
Genome Scan of a Jordanian Family with AE
Marker
Maximum Total
Two-Point LOD Score v
D1S1589 1.48 .001
D2S1356 1.48 .001
D6S1021 .78 .001
D7S3051 .92 .001
D8S256 .75 .100
D8S373 1.94 .001
D10S212 .77 .001
D16S3253 .93 .001
D19S245 1.03 .001
ing radioisotopes may be performed in vivo or in vitro.
If such tests are unavailable, the clinical response to a
daily dose of 3–30 mmol of zinc supplement/kg of body
weight, for 5 d, may establish the diagnosis (Krieger
1982, pp. 258–262).
Grider and Young (1996) provided evidence that the
AE mutation transiently affects zinc metabolism in hu-
man fibroblasts. The activity of the zinc-dependent en-
zyme, 5′ nucleotidase, and cell-zinc content were both
significantly reduced in AE fibroblasts, compared with
those in a normal control. AE fibroblasts also exhibited
slower-than-normal zinc uptake.
The biochemical mechanism underlying the zinc-
transport defect caused by the AE mutation is still un-
known. Analysis of the expression patterns between AE
and normal human fibroblasts by two-dimensional gel
electrophoresis (Grider and Mouat 1998) and differen-
tial display (Muga and Grider 1999) identified several
genes that were either down- or up-regulated in AE sam-
ples. However, no clear indication of how these changes
contributed to the AE phenotype was found; conse-
quently, we have embarked on a genetic approach to
discovering the underlying etiology of AE.
In this study, we sought to localize the genetic defect
responsible for AE, by homozygosity mapping (Lander
and Botstein 1987) using consanguineous families with
affected individuals that were from Jordan and Egypt.
We obtained informed consent either from all family
members who agreed to participate in the study or from
their legal guardians. The proband of the Jordanian fam-
ily (fig. 1A; filter card in fig. 1B) was first seen at age 5
mo, with a 1-mo history of diaper rash that was resistant
to antifungal treatment. The proband’s zinc level was
2.2 mmol/liter, whereas the normal reference value for
that age group is 9.8–16.8 mmol/liter. There was dra-
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Figure 2 Pedigrees of seven consanguineous Egyptian families with genotypes of 10 microsatellite markers at 8q24.3. For compactness,
only the relevant portions of the pedigrees are shown. Haplotypes/markers that are homozygous in affected individuals are boxed.
matic improvement with treatment with zinc sulfate (2
mg/kg/d), within a period of 1 wk. Individual 97030
(fig. 1B) is a younger sister of the proband, with a very
similar presentation of diaper rash and diarrhea, and,
because of the family history, diagnosis was made with-
out testing of her zinc level. She responded excellently
to the same treatment and dosage given the proband.
Similar symptoms were observed in individuals 97025,
97029, and 97032 (fig. 1B). All were given the same
treatment of zinc sulfate, with good response.
We first performed a genomewide scan of 17 individ-
uals, including 4 affected individuals, from the Jordanian
family (pedigree 21; fig. 1B), using a modification of the
Weber version 9 marker set (383 microsatellite markers,
mean spacing 9 cM, and mean heterozygosity .76). Four
blind duplicate samples were placed on each 96-well
plate, to assess the amount of genotyping error. For this
project and two other concurrent runs, the error rate
was 0.15%, on the basis of 3,560 paired genotypes.
We compared the number of alleles present in affected
individuals (97025, 97029, 97030, and 97032), unaf-
fected siblings (97019, 97023, 97033, 97034, and
97037), and parents (97018, 97021, 97022, 97024,
97027, 97028, 97031, and 97038), simulating a pooling
experiment. Results at three loci—D10S212, D8S373,
and D6S1021—were consistent with the pattern ex-
pected for an autosomal recessive disease—namely, one
allele in the affected individuals and multiple alleles in
the unaffected sibs and parents. Moreover, for marker
D8S256, adjacent to D8S373, a shift toward homozy-
gosity among the affected sibs was also observed. These
data pointed to the chromosomal region 8q24.3 near
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Table 2
Two-Point LOD Scores for Markers at 8q24.3
MARKER
LOCATION
(cM)
LOD SCORE AT v p
.0 .01 .05 .1 .2 .3 .4
D8S264 .73  7.22 3.57 2.06 .81 .29 .07
D8S1130 22.41  4.47 1.89 .93 .22 .01 .06
D8S1106 26.43 5.24 3.20 1.47 .75 .21 .04 .00
D8S1145 37.04 1.75 1.09 .63 .47 .24 .10 .03
D8S136 43.96 .31 .51 .99 1.05 .87 .59 .29
D8S1771 50.05 1.80 1.00 .50 .30 .10 .10 .00
D8S1477 60.34 1.59 1.20 .28 .07 .23 .18 .07
D8S1110 67.27 4.57 2.84 1.23 .67 .33 .21 .12
D8S1113 77.89 1.34 .50 .02 .16 .18 .12 .05
D8S1136 82.26  1.91 .32 .24 .46 .31 .08
D8S2324 94.08  4.05 1.83 .88 .17 .01 .02
D8S1119 101.01 4.46 2.87 1.27 .65 .22 .09 .05
D8S1132 … 7.21 5.23 3.01 1.92 .91 .42 .15
D8S592 125.27 3.75 2.19 1.06 .64 .32 .18 .07
D8S1128 139.53  2.86 1.68 1.02 .44 .17 .04
D8S256 148.12 .75 1.08 1.45 1.35 .89 .44 .14
D8S1710 150.80  .56 .37 .79 .88 .67 .36
D8S1783 154.02 1.07 1.12 1.68 1.82 1.54 1.02 .46
D8S1837 156.59  .17 .33 .32 .11 .08 .07
D8S1743 162.94 .63 .52 .52 .40 .01 .06 .03
D8S1741 162.94 .25 .13 .62 .92 .87 .62 .32
D8S1704 164.25 .02 .10 .78 .91 .73 .58 .34
D8S1713 164.38 2.34 2.21 2.15 1.98 1.32 .75 .33
D8S373 164.47 2.39 2.26 2.18 1.97 1.18 .64 .30
D8S1727 164.81 2.80 2.67 2.18 1.60 .76 .42 .22
D8S1744 164.81 4.54 4.42 3.90 3.26 2.12 1.25 .59
D8S1836 165.93 1.76 1.62 1.50 1.30 .80 .53 .28
D8S2334 167.90 3.35 3.24 2.79 2.20 1.08 .28 .00
D8S373 and D8S256 as being a possible candidate lo-
cation for the AE gene.
The possibility that chromosomal region 8q24.3 is the
location of the AE gene was supported by two types of
linkage analysis. We used FASTLINK (Lathrop et al.
1984; Cottingham 1993) for two-point parametric link-
age analysis of the genotyping data, to find the maxi-
mum LOD score for each marker. An autosomal reces-
sive–inheritance pattern with gene frequency .001 and
100% penetrance was assumed, and marker-allele fre-
quencies were estimated from the data. This analysis iden-
tified one region defined by two markers with maxi-
mum LOD scores 0.75: 1.94 (recombination fraction
[v]p.001) at D8S373 and 0.75 ( ) at D8S256vp .100
(table 1). Nonparametric linkage analysis using the Hase-
man-Elston (Haseman and Elston 1972) method as im-
plemented in Sib-pair (Duffy 1997) identified the same
region, with : at D8S256, andP ! .05 Pp .0098 Pp
at D8S373. Three analyses suggested the 8q24.3.0361
region near markers D8S373 and D8S256 as being the
possible AE candidate region.
On the basis of these results, we further genotyped
the extended Jordanian family (fig. 1B), for 11 addi-
tional markers from D8S256 to the telomere. Two in-
dividuals (97022 and the spouse of 97036) who were
distant relatives of the family share with other family
members a haplotype that segregates with the disease.
The shared haplotype spans a 3.5-cM interval from
marker D8S1713 to the telomeric marker D8S2334
(fig. 1B). Several recombination events were observed in
this pedigree, but none narrowed the candidate region
further.
The 10 most distal markers of 8q24.3 were then used
to genotype seven consanguineous families from Egypt,
as shown in figure 2. Of the eight affected individuals,
six (from pedigrees 1, 2, 3, 9, and 11; fig. 2) were shown
to be homozygous for most of the loci, whereas none
of the unaffected relatives were similarly homozygous.
A closer examination of the genotyping data revealed
that unaffected individual IV2 in pedigree 1 is homo-
zygous for the two most distal markers, D8S1836 and
D8S2334. If this region is homozygous by descent, it
would be excluded from the candidate interval, nar-
rowing it to 1.5 cM. However, genotyping of additional
markers would be needed to draw this conclusion. Pa-
tient 303 from pedigree 3 presented a paradox, being
heterozygous (with alleles 5 and 6) for markerD8S1727
but homozygous for neighboring markers. An unlikely
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Figure 3 Graph of three-point and multipoint LOD scores, against distance (in cM), at 8q24.3. For sliding three-point analysis, the
maximum LOD score is 5.16. Homozygosity mapping gives a maximum LOD score of 3.89. Mapmaker/Homoz was used for homozygosity
mapping.
possible explanation is that marker locations are not
accurate. Other possible explanations include a calling
error or a prior change in size of the microsatellite.
Two other findings are notable. First, different hap-
lotypes are found in all homozygous patients, arguing
against the hypothesis of a common origin for AE in the
Egyptian population. Second, the two patients from ped-
igrees 13 and 20 showed no significant homozygosity in
chromosomal region 8q24.3. Although this finding may
suggest the existence of another locus that could cause
AE, we also note that patient 2002 has no records of
zinc-level measurement and response to zinc-supplement
therapy. Given the difficulty of AE diagnosis, we cannot
exclude the possibility of a misdiagnosis.
By parametric analysis using FASTLINK, a maxi-
mum two-point LOD score of 4.54 was found at marker
D8S1744 (table 2). Mapmaker/Homoz was used to cal-
culate multipoint LOD scores for all eight consanguin-
eous families, by homozygosity mapping (Kruglyak et
al. 1995). The maximum LOD score obtained in this
region was 3.89 (fig. 3). Sliding three-point analysis of
the same families was also performed using FASTLINK
(Terwilliger and Ott 1994). The maximum LOD score
obtained was 5.16 between markers D8S1727 and
D8S1744.
We conclude that AE maps within a 3.5-cM interval
near the telomere on chromosomal region 8q24.3. A
search of GeneMap’99 in this region revealed 170
known genes and UniGene clusters in this interval. Re-
search is underway to test these candidates for expres-
sion in the intestine and for mutations that cause AE.
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